| Ambetter Health Texas Superior Marketplace Clinical | Tocilizumab and Biosimilars | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Ustekinumab and Biosimilars | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Vedolizumab | 2025-11-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | No Coverage Criteria, Recent Label Changes Pending | 2025-11-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Risankizumab-rzaa | 2025-11-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Sarilumab | 2025-11-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Secukinumab | 2025-11-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Tildrakizumab-asmn | 2025-11-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Tocilizumab and Biosimilars | 2025-11-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Ustekinumab and Biosimilars | 2025-11-01 |